Actively Recruiting

Age: 0 - 45Years
FEMALE
ID07461519

Gonadic Function and Pubertal Development in Female Patients With Classic Galactosemia

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2026-03-10

60

Participants Needed

19

Research Sites

26 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying female patients with classic galactosemia to better understand long-term complications such as primary ovarian insufficiency (POI), which affects ovarian function and fertility. Despite improvements in early outcomes through newborn screening and a galactose-free diet, POI remains a significant concern. This large multicenter Italian observational study aims to clarify clinical, hormonal, developmental, and fertility-related factors in affected girls and women. The study involves female patients diagnosed with classic galactosemia confirmed by genetic testing, born between 1980 and 2024, and followed at specialized centers. It compares their pubertal development, clinical features, and hormone levels with those of the general population at key stages including infancy, childhood, puberty, and adulthood before menopause. It also investigates factors contributing to POI and describes fertility characteristics, as well as evaluating height achievement, quality of life, psycho-emotional adjustment, and cognitive development. Participants will undergo assessments at different life stages focusing on clinical and auxological features, hormonal profiles, and developmental evaluations. Researchers will track growth relative to familial targets and assess quality of life and emotional well-being. Outcomes include identifying POI-related factors and fertility status. The study spans from infancy through adulthood up to age 45, with ongoing observation to enhance understanding of galactosemia's impact on female reproductive health.

CONDITIONS

Brief Title

Gonadic Function and Pubertal Development in Female Patients With Classic Galactosemia

Who Can Participate

Age: 0 - 45Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female patients followed at participating Pediatric Endocrinology and Inherited Metabolic Disease Centers
  • Born between January 1, 1980 and December 31, 2024
  • Diagnosis of classic galactosemia confirmed by genetic testing
  • Informed consent obtained
Not Eligible

You will not qualify if you...

  • Known chromosomal abnormalities such as trisomy 21, Turner syndrome, Fragile X syndrome, or Kabuki syndrome
  • Primary ovarian insufficiency caused by factors other than galactosemia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - From 3 months to adulthood before menopause

Participants undergo assessments to compare clinical, auxological, and hormonal features at key stages of pubertal development.

Visits scheduled according to participant's age group and development stage

Long-term Monitoring

Duration - Up to adulthood before menopause

Participants are observed over time to identify factors contributing to primary ovarian insufficiency and to assess fertility-related and growth outcomes.

Periodic visits depending on age and clinical status

Trial Site Locations

Total: 19 locations

1

SSD Nutrizione Clinica e Metabolismo - IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Italy, Italy, 40138

Actively Recruiting

2

UOC Pediatria - IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Italy, Italy, 40138

Actively Recruiting

3

Ospedale Pediatrico "Giovanni XXIII"

Bari, Italy

Not Yet Recruiting

4

Ospedale Pediatrico Microcitemico "A. Cao"

Cagliari, Italy

Not Yet Recruiting

5

AOU Policlinico di Catania

Catania, Italy

Not Yet Recruiting

6

AOU "Dulbecco", Policlinico Germaneto-Università di Catanzaro

Catanzaro, Italy

Not Yet Recruiting

7

Azienda Ospedaliera Universitaria Meyer IRCCS

Florence, Italy

Actively Recruiting

8

IRCCS Istituto G. Gaslini

Genova, Italy

Actively Recruiting

9

AOU Policlinico G. Martino

Messina, Italy

Not Yet Recruiting

10

ASST Santi Paolo e Carlo - Presidio San Paolo - Università degli studi di Milano

Milan, Italy

Not Yet Recruiting

11

Ospedale dei Bambini "Vittore Buzzi"

Milan, Italy

Not Yet Recruiting

12

Fondazione IRCCS San Gerardo dei Tintori

Monza, Italy

Actively Recruiting

13

AORN Santobono Pausilipon

Naples, Italy

Not Yet Recruiting

14

Azienda Ospedaliera Universitaria "Federico II"

Naples, Italy

Not Yet Recruiting

15

Azienda Ospedale-Università di Padova

Padova, Italy

Not Yet Recruiting

16

Ospedale dei Bambini di Palermo

Palermo, Italy

Not Yet Recruiting

17

Ospedale Guglielmo da Saliceto

Piacenza, Italy

Actively Recruiting

18

Ospedale Pediatrico Bambin Gesù IRCCS

Roma, Italy

Actively Recruiting

19

Ospedale Infantile Regina Margherita, AOU Città della Salute e della Scienza di Torino

Torino, Italy

Not Yet Recruiting

Loading map...

Research Team

R

Rita Ortolano

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Gonadal Tissue Freezing for Fertility Preservation in Indivi...

Turner Syndrome

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here